Prevalent‐New User Design for Biosimilar Safety Using Saudi Real‐World Data

Documenti analoghi

• Real‐World Evidence of Indapamide‐Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health Records
  di: Raseel Alroba, et al.
  Pubblicazione: (2024)
• The Risk of Hypothyroidism With the Use of GLP ‐1 Receptor Agonists in Saudi Arabia
  di: Almaha Alfakhri, et al.
  Pubblicazione: (2026)
• Empirical Comparison of Exposure Set Definitions in the Prevalent New‐User Design
  di: John Tazare, et al.
  Pubblicazione: (2026)
• The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia
  di: Wanqi Wang, et al.
  Pubblicazione: (2024)
• Evaluating the Impact of Data Standardization on Real‐World Data
  di: Elizabeth M. Garry, et al.
  Pubblicazione: (2025)